Hypoxia-inducible enhancer/α-fetoprotein promoter-driven RNA interference targeting STK15 suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Hypoxia-inducible enhancer/α-fetoprotein promoter-driven RNA interference targeting STK15 suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells

Published:2008-09-18 Issue:11 Volume:99 Page:2209-2217
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Gao Ping,Wang Rui,Shen Jian-Jun,Lin Fang,Wang Xi,Dong Ke,Zhang Hui-Zhong

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2008.00941.x/fullpdf

Reference49 articles.

1. Hepatocellular carcinoma pathogenesis: from genes to environment;Farazi;Nat Rev Cancer,2006

2. Rising incidence of hepatocellular carcinoma in the United States;El-Serag;N Engl J Med,1999

3. Global cancer statistics 2002;Parkin;CA Cancer J Clin,2005

4. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study;Davila;Gastroenterology,2004

5. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation;Zhou;Nat Genet,1998

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanogel enhances the efficacy of MLN8237 in treating hepatocellular carcinoma;Journal of Biomaterials Applications;2023-09-11

2. Aurora kinase: An emerging potential target in therapeutics;Protein Kinase Inhibitors;2022

3. MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance;Cancer Genomics - Proteomics;2019-12-27

4. Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway;BMC Cancer;2019-11-08

5. A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma;Molecular Therapy - Nucleic Acids;2018-12